We propose to map and identify genes in disorders of the motor neuron. We will use genetic linkage analysis to identify the chromosome localization of the genes for: (1) autosomal dominant form of familial amyotrophic lateral sclerosis in those (30% - 60%) families where the gene for this disease is not linked to chromosome 21. (2) Autosomal recessive and autosomal dominant forms of pure spastic paraplegias. Our laboratory is well suited for this task as we have DNA samples from families with these disorders and have recently identified chromosome loci for the autosomal dominant and autosomal forms of amyotrophic lateral sclerosis on chromosome 21q and 2q respectively. In addition we have preliminary evidence for linkage of recessive familial spastic paraplegia to chromosome 8. We plan to identify the gene for recessive amyotrophic lateral sclerosis on chromosome 2q. We will use genetic linkage techniques to fine map this gene, then use molecular techniques to obtain a physical map of that region and then identify candidate genes for this disease. These techniques include identifying Yeast artificial chromosomes that map to this region which will be used along with a microdissected chromosome 2 library to find closely linked polymorphic markers. Once markers within a million base pairs or so of the gene are obtained, it will be possible to prepare a physical (YAC/cosmid and pulsed field) map of the region based. Potential candidate genes can then be identified and should be contained in the microdissected library or in appropriate yeast artificial chromosome clones. cDNA libraries from the spinal cord will also be screened with clones from regional genomic libraries prepared from microdissected chromosome 2 to obtain candidate genes. Candidate genes can then be tested for their relevance by linkage analysis in our recessive ALS families. Similar techniques will be used to identify genes for amyotrophic lateral sclerosis (non chromosome 21) and the spastic paraplegias. Once the location of those genes are determined, identification of these genes and their function will allow the formulation of rational treatment and or prevention of those disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS021442-10
Application #
3760719
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Thomas, Ajit G; Bodner, Amos; Ghadge, Ghanashyam et al. (2009) GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity. J Neurovirol 15:449-57
Haley, Benjamin; Paunesku, Tatjana; Proti?, Miroslava et al. (2009) Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair. Int J Radiat Biol 85:643-55
Paunesku, T; Chang-Liu, C M; Shearin-Jones, P et al. (2000) Identification of genes regulated by UV/salicylic acid. Int J Radiat Biol 76:189-98
Glaum, S R; Brooks, P A (1996) Tetanus-induced sustained potentiation of monosynaptic inhibitory transmission in the rat medulla: evidence for a presynaptic locus. J Neurophysiol 76:30-8
Brooks, P A; Glaum, S R (1995) GABAB receptors modulate a tetanus-induced sustained potentiation of monosynaptic inhibitory transmission in the rat nucleus tractus solitarii in vitro. J Auton Nerv Syst 54:16-26
Glaum, S R; Miller, R J (1995) Presynaptic metabotropic glutamate receptors modulate omega-conotoxin-GVIA-insensitive calcium channels in the rat medulla. Neuropharmacology 34:953-64
Siddique, T (1991) Molecular genetics of familial amyotrophic lateral sclerosis. Adv Neurol 56:227-31